EZH2 and cervical carcinoma: In addition, miR-138 expression can be regulated by demethylating agents in vitro and vivo. Together, these findings both clarified the regulatory role of miR-138 on EZH2 expression in cervical carcinogenesis and illustrated the potential use of demethylating agents in cervical cancer treatment.